Patent details

Basic Information

Publication number:

92698

Type:

SPC

SPC Type:

Medical

Basic Patent Number:

EP047594049

Legal Status:

Active

Application number:

92698

First applicant's nationality:

Procedural language:

French

Marketing Authorization

Marketing Authorization Number:

EU/1/13/902 Translarna-Ataluren

Marketing Authorization Type:

Marketing Authorization Date:

31/07/2014

Marketing Authorization Status:

Accepted

Marketing Authorization Country:

Dates

Filing date:

20/04/2015

First Marketing Authorization date:

31/07/2014

Grant date:

22/06/2015

Activation date:

09/04/2024

Publication date:

22/06/2015

Lapsed date:

Expiration date:

Renunciation date:

Revocation date:

Annulment date:

Basic SPC Expiration:

09/04/2029

SPC Extension Expiration:

09/04/2029

Rejection date:

Withdrawal date:

Owner

From:

20/04/2015

 

 

Name:

PTC Therapeutics Inc.

Address:

100 Corporate Court, Middlesex Business Center, South Plainfield, NJ 07080, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

20/04/2015

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

HWANG Seongwoo

Address:

United States (US)

2

Name:

CHEN Guangming

Address:

United States (US)

3

Name:

KARP Gary, Mitchell

Address:

United States (US)

4

Name:

MOON Young-Choon

Address:

United States (US)

5

Name:

ALMSTEAD Neil, Gregory

Address:

United States (US)

Publication

Bulletin

Bulletin Heading:

SPC3

Bulletin edition number:

2025/04

Publication date:

04/03/2025

Description:

Section E : Supplementary Protection certificates entered into force – IA publication

Annual Fees

Annual Fee Due Date:

30/04/2027

Annual Fee Number:

24

Annual Fee Amount:

440 Euro

Expected Payer:

Last Annual Fee Payment Date:

19/03/2026

Last Annual Fee Paid Number:

23

Last Annual Fee Paid Amount:

430 Euro

Payer:

ANAQUA SERVICES (ANC. SGA2)

Filing date	Document type	Number of pages